Healthcare Commercial Due Diligence Services
Healthcare commercial due diligence is the process by which buyers of healthcare assets and businesses conduct systematic investigations addressing commercial issues before making investment decisions. BiopharmaVantage is a specialist provider of healthcare commercial due diligence services to private equity investors, venture capital investors and corporate clients seeking to make investment decisions either organically or inorganically. We take pride in performing rigorous healthcare and life sciences due diligence leveraging extensive primary research (KOL interviews), structured secondary research and superior analysis.
Due Diligence: Our Differentiation
- Our healthcare commercial due diligence team consists of scientists and doctors who have business experience and education; thus, we provide granular insights while retaining top-level CEO and Investors’ perspective.
- We also have unrivalled access to KOLs as well as Corporate Executives for primary research, whose input we incorporate in our commercial due diligence exercises.
- Addressable markets and Market sizing
- Peak sales assessment
- Competitive landscape – current competitors
- Competitive landscape – future competitors
- Market opportunity assessment
- Scientific and Clinical assessment
- KOL interviews – Primary Research
- New Product Planning
- Pricing and Reimbursement studies
- Asset, Opportunity and Company Valuation
- Growth Strategy
- Exit Strategy
Our Due Diligence Services Coverage
- Scientific due diligence
- Clinical due diligence
- Commercial due diligence
- Regulatory due diligence
- IP due diligence
- Manufacturing due diligence
Post Due Diligence and Investment Support Services
- Once the investment is made, we also assist you with the strategy of the company.
- We often work with you and the management of the investee company regarding growth strategy, market and products expansion plan, new product planning, growth strategy, commercial opportunity assessments, and business development via inorganic route i.e. licensing, partnering and M&A.
- We also help you and your portfolio companies with valuation services for a variety of reasons.
